Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 2
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Gemcitabine
×
Clear all
Filters
3
NCT06788912
2026-03-10
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2
Recruiting
60 enrolled
NCT04191135
2026-03-03
KEYLYNK-009
Merck Sharp & Dohme LLC
Phase 2
Completed
462 enrolled
30 charts
NCT05007106
2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2
Completed
613 enrolled